Novarel Recall: Missing Anaphylaxis Warning on Label
Ferring Pharmaceuticals recalls Novarel (NDC 55566-1501-1) due to missing anaphylaxis warnings in the package insert. Check your lot numbers.
Use caution until it’s fixed
Labeling; incorrect or missing insert; Warnings portion of the Package Insert is missing the warning statement: Anaphylaxis has been reported with urinary-derived hCG products.
Contact the company
What happened, in plain English
Ferring Pharmaceuticals Inc is recalling specific lots of Novarel, a chorionic gonadotropin injection used for intramuscular administration. The recall addresses a labeling defect where the package insert fails to include a required warning that anaphylaxis has been reported with urinary-derived hCG products. Because the remedy is not stated in this record, consumers should contact their healthcare provider for guidance on how to proceed. Read more at govinfonow.com/recall/48592-ferring-pharmaceuticals-inc-recalls-novarel-chorionic-gonadotropin-for-injection-usp.
Source Summary by GovInfoNow · govinfonow.com/recall/48592-ferring-pharmaceuticals-inc-recalls-novarel-chorionic-gonadotropin-for-injection-usp · Updated October 13, 2026 · FDA enforcement record: FDA #D-073-2013
Cite this page
“Novarel Recall: Missing Anaphylaxis Warning on Label.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48592-ferring-pharmaceuticals-inc-recalls-novarel-chorionic-gonadotropin-for-injection-usp. Based on FDA recall #D-073-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-073-2013%22&limit=1).
Why it’s dangerous
The missing warning statement means patients and healthcare providers may not be alerted to the potential for anaphylaxis, a severe allergic reaction, when using this urinary-derived hCG product. Without this information, individuals might not recognize or prepare for this serious side effect during normal use.
Who’s affected
Patients prescribed Novarel for fertility treatments who have received lots manufactured by DRAXIS Specialty Pharmaceuticals Inc. between 2012 and early 2013 are at risk of being unaware of the anaphylaxis warning.
How to tell if you have this one
Check your Novarel carton for NDC # 55566-1501-1 and verify the lot number against the following list: 1C264A (Exp 09/12), 1H047A (Exp 12/12), 1H047B (Exp 12/12), 1H052A (Exp 12/12), 1H052B (Exp 04/13), 1H052C (Exp 04/13), 1M417A (Exp 04/13), 1M417B (Exp 09/13), 2A012A (Exp 09/13), 2A012B (Exp 11/13), 2C278A (Exp 09/13), 2C278B (Exp 09/13), 2C278C (Exp 11/13), 2C278D (Exp 11/13), or 2C278E (Exp 11/13).
- Brand
Novarel- Category
Drug
What to do — step by step
Check Your Lot Number
Compare the lot number on your Novarel carton against the recalled list provided in the record to see if your product is affected.
Contact Healthcare Provider
Speak with your doctor or pharmacist immediately, as the specific remedy for this recall is not stated in the official record.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What is the specific NDC number for the recalled product?
The recalled item is identified by NDC # 55566-1501-1, which is displayed on the unit of sale (carton containing 1 vial of NOVAREL and 1 vial of diluent).
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-073-2013 (August 23, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-073-2013 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.